Immediate Impact
60 standout
Citing Papers
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of David Wright being referenced
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)
2019
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David Wright | 259 | 153 | 93 | 127 | 30 | 611 | |
| M. Stas | 137 | 94 | 337 | 41 | 25 | 638 | |
| David C. Calverley | 104 | 116 | 106 | 127 | 31 | 696 | |
| Daniela Belotti | 79 | 53 | 33 | 165 | 19 | 698 | |
| Rui Niimi | 252 | 163 | 149 | 91 | 41 | 712 | |
| Maurizio Romano | 329 | 11 | 203 | 114 | 44 | 733 | |
| Venkatesh Krishnasamy | 159 | 70 | 147 | 34 | 37 | 558 | |
| Valérie Eschwège | 86 | 87 | 66 | 163 | 29 | 733 | |
| Francesco Snider | 194 | 45 | 313 | 112 | 39 | 597 | |
| Yuka Jiuchi | 126 | 46 | 53 | 265 | 29 | 561 | |
| Mariangela Scavone | 74 | 61 | 43 | 60 | 30 | 565 |
All Works
Login with ORCID to disown or claim papers
Loading papers...